Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:57 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 50,492 | $0 | 80,106 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:22 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 7:01 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 39,897 | $0 | 56,589 (Direct) | View |
2022-06-22 Option Award | 2022-06-24 5:38 pm | N/A 2032-06-21 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 51,337 | $0 | 51,337 (Direct) | View |
2022-06-09 Option Award | 2022-06-10 4:23 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 19,872 | $0 | 19,872 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 5:10 pm | N/A 2032-02-27 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 22,581 | $0 | 22,581 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 4:31 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 19,872 | $0 | 19,872 (Direct) | View |
Ownership | 2021-06-17 5:02 pm | N/A 2031-05-21 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 0 | $0 | 99,483 (Direct) | View |